Relmada Therapeutics, Inc. (RLMD) vs Turn Therapeutics Inc. (TTRX)
Relmada Therapeutics, Inc. and Turn Therapeutics Inc. are both Biotechnology companies. Relmada Therapeutics, Inc. and Turn Therapeutics Inc. are of similar size ($406.4M and $395.0M). Across the 9 metrics below, Relmada Therapeutics, Inc. leads on 6 and Turn Therapeutics Inc. on 3.
Valuation
Profitability
| Metric | RLMD | TTRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (55.66%) | (3,315.33%) | (57.72%) |
| Return on assets | (51.57%) | (99.59%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack